Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Molecular and Cellular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9584188PMCID PMC108929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential use of CREB binding protein-coactivator complexes.

  1998cited by this paper
• Transcription factor-specific requirements for coactivators and their acetyltransferase functions.

  1998cited by this paper
• Engineering novel specificities for ligand-activated transcription in the nuclear hormone receptor RXR.

  1998cited by this paper
• The enhanceosome and transcriptional synergy.

  1998cited by this paper
• The phantom ligand effect: allosteric control of transcription by the retinoid X receptor.

  1997cited by this paper
• Heterodimeric interaction between retinoid X receptor alpha and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation

  1997cited by this paper
• Nuclear receptor coactivators.

  1997cited by this paper
• Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression

  1997cited by this paper
• Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR.

  1997cited by this paper
• Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

  1997cited by this paper
• The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

  1997cited by this paper
• Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

  1997cited by this paper
• Steroid receptor coactivator-1 is a histone acetyltransferase

  1997cited by this paper
• Transcriptional activation by recruitment

  1997cited by this paper
• Stoichiometric and steric principles governing repression by nuclear hormone receptors.

  1997cited by this paper
• Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

  1997cited by this paper
• Regulating Adipogenesis*

  1997cited by this paper
• GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors

  1997cited by this paper
• Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

  1997cited by this paper
• Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors.

  1997cited by this paper
• RNA helicase A mediates association of CBP with RNA polymerase II.

  1997cited by this paper
• p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha.

  1997cited by this paper
• Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance.

  1996cited by this paper
• Transcriptional control: how nuclear receptors get turned on.

  1996cited by this paper
• A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

  1996cited by this paper
• p300 is a component of an estrogen receptor coactivator complex.

  1996cited by this paper
• The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.

  1996cited by this paper
• TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors.

  1996cited by this paper
• A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

  1996cited by this paper
• A canonical structure for the ligand-binding domain of nuclear receptors

  1996cited by this paper
• Role of CBP/P300 in nuclear receptor signalling

  1996cited by this paper
• The CBP co-activator is a histone acetyltransferase

  1996cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.

  1996cited by this paper
• Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states

  1996cited by this paper
• Adaptor-mediated Recruitment of RNA Polymerase II to a Signal-dependent Activator (*)

  1996cited by this paper
• CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.

  1996cited by this paper
• Activation of specific RXR heterodimers by an antagonist of RXR homodimers

  1996cited by this paper
• Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

  1995cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

  1995cited by this paper
• Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

  1995cited by this paper
• A structural role for hormone in the thyroid hormone receptor

  1995cited by this paper
• Polarity-specific activities of retinoic acid receptors determined by a co-repressor

  1995cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α

  1995cited by this paper
• The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing

  1995cited by this paper
• An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

  1995cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Transcriptional coactivators in yeast and beyond.

  1995cited by this paper
• Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation.

  1995cited by this paper
• Mutagenesis of the Ligand Binding Domain of the Human Retinoic Acid Receptor α Identifies Critical Residues for 9-cis-Retinoic Acid Binding (*)

  1995cited by this paper
• Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

  1995cited by this paper
• 9-cis retinoic acid signaling: changing partners causes some excitement.

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

  1995cited by this paper
• Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping

  1994cited by this paper
• Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival.

  1994cited by this paper
• Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

  1994cited by this paper
• Ligand-induced alteration of the protease sensitivity of retinoid X receptor alpha.

  1994cited by this paper
• The role of activators in assembly of RNA polymerase II transcription complexes.

  1994cited by this paper
• Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha

  1994cited by this paper
• Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor.

  1993cited by this paper
• Synergism in transcriptional activation: a kinetic view.

  1993cited by this paper
• Functional ecdysone receptor is the product of EcR and Ultraspiracle genes

  1993cited by this paper
• Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding.

  1993cited by this paper
• Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.

  1993cited by this paper
• Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants.

  1993cited by this paper
• Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.

  1992cited by this paper
• Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

  1992cited by this paper
• A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain.

  1992cited by this paper
• The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.

  1992cited by this paper
• Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding.

  1992cited by this paper
• Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

  1991cited by this paper
• Steroid binding activity is retained in a 16-kDa fragment of the steroid binding domain of rat glucocorticoid receptors.

  1989cited by this paper

• Engineered Genetic Circuits Activated by Bezafibrate Improve ESC‐Based TAA Cancer Vaccine Efficacy and PD‐L1 Nanobody Therapy

  2025cites this paper
• Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology

  2024cites this paper
• PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments

  2024cites this paper
• TGS1/PIMT knockdown reduces lipid accumulation in adipocytes, limits body weight gain and promotes insulin sensitivity in mice.

  2023cites this paper
• An intronic enhancer of Cebpa regulates adipocyte differentiation and adipose tissue development via long‐range loop formation

  2023cites this paper
• Binding of Per- and Polyfluoroalkyl Substances (PFAS) to the PPARγ/RXRα-DNA Complex

  2023cites this paper
• Adipogenic and osteogenic effects of OBS and synergistic action with PFOS via PPARγ-RXRα heterodimers.

  2023cites this paper
• Conjugated linoleic acid regulates adipocyte fatty acid binding protein expression via peroxisome proliferator-activated receptor α signaling pathway and increases intramuscular fat content

  2022cites this paper
• Nuclear receptors in oral cancer-emerging players in tumorigenesis.

  2022cites this paper
• Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects

  2022influential citation
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.

  2021cites this paper
• Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.

  2021cites this paper
• Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ

  2021cites this paper
• Identifying adipogenic chemicals: Disparate effects in 3 T3-L1, OP9 and primary mesenchymal multipotent cell models.

  2020cites this paper
• PPARs and Microbiota in Skeletal Muscle Health and Wasting

  2020cites this paper
• The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies

  2020cites this paper
• Mechanisms underlying N3-PUFA regulation of white adipose tissue endocrine function.

  2020cites this paper
• Tributyltin and triphenyltin induce 11β-hydroxysteroid dehydrogenase 2 expression and activity through activation of retinoid X receptor α.

  2020cites this paper
• Sex-regulated gene dosage effect of PPARα on synaptic plasticity

  2019cites this paper
• Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum

  2019cites this paper
• Métabolisme des rétinoïdes et facteurs d’influence dans l’obésité, la résistance à l’insuline et le diabète de type 2 : études chez l’animal et chez l’homme

  2018cites this paper
• Molecular Actions of PPARα in Lipid Metabolism and Inflammation.

  2018cites this paper
• Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches

  2018cites this paper
• Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis

  2018cites this paper
• Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models

  2018cites this paper
• Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ–Retinoid X Receptor α Coactivator

  2018cites this paper
• A Phytol‐Enriched Diet Activates PPAR‐&agr; in the Liver and Brown Adipose Tissue to Ameliorate Obesity‐Induced Metabolic Abnormalities

  2018cites this paper
• Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation

  2017cites this paper
• Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator–activated receptor γ (PPARγ) during adipocyte differentiation

  2017cites this paper
• Transcriptional control of ATGL by Sp 1 and PPARγ 1 Coordinated Transcriptional Control of Adipocyte Triglyceride Lipase ( Atgl ) by transcription factors Sp 1 and PPARγ during Adipocyte Differentiation

  2017cites this paper
• New Transcriptional Reporters to Quantify and Monitor PPARγ Activity

  2017cites this paper
• Multiple-stressor effects in an apex predator: combined influence of pollutants and sea ice decline on lipid metabolism in polar bears

  2017cites this paper
• Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology.

  2017cites this paper
• Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex

  2016cites this paper
• Galectin‐12 inhibits granulocytic differentiation of human NB4 promyelocytic leukemia cells while promoting lipogenesis

  2016cites this paper
• SIRT1‐mediated ERβ suppression in the endothelium contributes to vascular aging

  2016cites this paper
• Relationship between Single Nucleotide Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Gene and Fatty Acid Composition in Korean Native Cattle

  2015cites this paper
• RXR partial agonist produced by side chain repositioning of alkoxy RXR full agonist retains antitype 2 diabetes activity without the adverse effects.

  2015cites this paper
• From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain.

  2014influential citation
• Integrated physiology and systems biology of PPARα

  2014cites this paper
• The Role of Estrogen Sulfotransferase in Human Adipogenesis

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• Differential activation of catalase expression and activity by PPAR agonists: Implications for astrocyte protection in anti-glioma therapy

  2013cites this paper
• PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells

  2013cites this paper
• Effects of PPARγ Ligands on Leukemia

  2012cites this paper
• Retinoid chemistry: synthesis and application for metabolic disease.

  2012cites this paper
• Coordinate Regulation of Lipid Metabolism by Novel Nuclear Receptor Partnerships

  2012cites this paper
• in press-uncorrected proof Peroxisome proliferator-activated receptor b / d : a master regulator of metabolic pathways in skeletal muscle

  2011cites this paper
• Regulation of remyelination in multiple sclerosis

  2011influential citation
• Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.

  2011cites this paper
• Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor α in Mouse Liver Reveals Extensive Sharing of Binding Sites

  2011cites this paper
• The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes.

  2011cites this paper
• Differential expression and cross-talk of peroxisome proliferator-activated receptor γ and retinoid-X receptor α in urothelial carcinomas of the bladder.

  2010cites this paper
• PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling

  2010cites this paper
• Epidermis-Type Lipoxygenase 3 Regulates Adipocyte Differentiation and Peroxisome Proliferator-Activated Receptor γ Activity

  2010cites this paper
• Research Resource: Transcriptome Profiling of Genes Regulated by RXR and Its Permissive and Nonpermissive Partners in Differentiating Monocyte-Derived Dendritic Cells

  2010cites this paper
• Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation.

  2010cites this paper
• PPARα and PPARγ are co‐expressed, functional and show positive interactions in the rat urinary bladder urothelium

  2009cites this paper
• Synthetic retinoids: structure-activity relationships.

  2009cites this paper
• Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor.

  2008cites this paper
• Hormone-Sensitive Lipase - New roles in adipose tissue biology

  2008cites this paper
• Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha.

  2008cites this paper
• Hormone-Sensitive Lipase-New roles in adipose tissue biology

  2008cites this paper
• RXR: from partnership to leadership in metabolic regulations.

  2007cites this paper
• PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL

  2007cites this paper
• Differential ability of a thiazolidinedione PPARγ agonist to attenuate cytokine secretion in primary microglia and macrophage‐like cells

  2007cites this paper
• Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes

  2007cites this paper
• Astrocyte-derived nitric oxide in manganese neurotoxicity: from cellular and molecular mechanisms underlying selective neuronal vulnerability in the basal ganglia to potential therapeutic modalities

  2007influential citation
• Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.

  2007cites this paper
• Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-γ and attenuates the oxidative burst

  2006cites this paper
• From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

  2006cites this paper
• Peroxisome proliferator‐activated receptor γ ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells

  2006cites this paper
• Fine-Tuning Reception in the Bone: PPARγ and Company

  2006cites this paper
• ANDROGEN RECEPTOR IN TRANSCRIPTIONAL REGULATION AND CARCINOGENESIS

  2006cites this paper
• Ligand control of coregulator recruitment to nuclear receptors.

  2005cites this paper
• Interactions of ultraspiracle with ecdysone receptor in the transduction of ecdysone‐ and juvenile hormone‐signaling

  2005cites this paper
• Biochemical and NMR Mapping of the Interface between CREB-binding Protein and Ligand Binding Domains of Nuclear Receptor

  2005cites this paper
• Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions.

  2005cites this paper
• Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor γ and Retinoic Acid X Receptors*

  2005cites this paper
• Effect of vitamin A content in cafeteria diet on the expression of nuclear receptors in rat subcutaneous adipose tissue

  2005cites this paper
• Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.

  2004cites this paper
• Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis.

  2004cites this paper
• Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity

  2004cites this paper
• Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes.

  2004cites this paper
• Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.

  2004cites this paper
• Capsaicin inhibits the production of tumor necrosis factor alpha by LPS-stimulated murine macrophages, RAW 264.7: a PPARgamma ligand-like action as a novel mechanism.

  2004cites this paper
• Laminar Flow Activates Peroxisome Proliferator–Activated Receptor-&ggr; in Vascular Endothelial Cells

  2004cites this paper
• PPARγ1 synthesis and adipogenesis in C3H10T1/2 cells depends on S‐phase progression, but does not require mitotic clonal expansion

  2004cites this paper
• Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.

  2004cites this paper
• Activation of nuclear receptors: a perspective from structural genomics.

  2003cites this paper
• Retinoid-X-receptor alpha (RXRalpha) expression during laryngeal carcinogenesis: detrimental or beneficial event?

  2003cites this paper
• Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.

  2003cites this paper
• Transcriptional control of adipogenesis.

  2003cites this paper
• Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms.

  2003cites this paper
• Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.

  2003cites this paper
• Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.

  2003cites this paper
• Activation‐induced PPARγ expression sensitizes primary human T cells toward apoptosis

  2003cites this paper
• Molecular and immunohistochemical investigations into fat deposition in Holstein and Charolais cattle

  2003cites this paper
• Peroxisome‐proliferator‐activated‐receptor gamma (PPARγ) independent induction of CD36 in THP‐1 monocytes by retinoic acid

  2002cites this paper
• Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?

  2002cites this paper